Clinical Pharmacology and Therapeutics - Table of Contents alert Volume 94 Issue 5

Advertisement Myriad RBM’s quantitative, multiplexed, immunoassay services have been successfully used in nearly 30 publications on diabetes and other metabolic disorders as part of a targeted proteomics approach to biomarker discovery and validation. Learn more about how our services meet the needs of researchers in this field TABLE OF CONTENTS Volume 94, Issue 5 (November 2013) In this issue In This Issue Editorial News & Views Perspectives Discovery & Development State of the Art Review Research Also new AOP Sign up for CPT: Pharmacometrics & Systems Pharmacology e-alerts Sign up for e-alerts Recommend to your library Web feed Subscribe In This Issue Top In This Issue Clin Pharmacol Ther 2013 94: 545; 10.1038/clpt.2013.180 Full Text Editorial Top Metabolomics: Integration of a New “Omics” with Clinical Pharmacology L P James Clin Pharmacol Ther 2013 94: 547-551; 10.1038/clpt.2013.166 Abstract | Full Text News & Views Top HIGHLIGHTS Clin Pharmacol Ther 2013 94: 552-553; 10.1038/clpt.2013.179 Full Text ASCPT NEWS Clin Pharmacol Ther 2013 94: 554-557; 10.1038/clpt.2013.173 Full Text Perspectives Top COMMENTARY Metabolomics in Drug Discovery and Development D G Robertson and U Frevert Clin Pharmacol Ther 2013 94: 559-561; 10.1038/clpt.2013.120 Abstract | Full Text Discovery & Development Top DISCOVERY Pharmacometabolomics of Statin Response R M Krauss, H Zhu and R Kaddurah-Daouk Clin Pharmacol Ther 2013 94: 562-565; advance online publication, August 14, 2013; 10.1038/clpt.2013.164 Abstract | Full Text Metabolic Phenotyping of Diabetic Nephropathy V-P Mäkinen, A J Kangas, P Soininen, P Würtz, P-H Groop and M Ala-Korpela Clin Pharmacol Ther 2013 94: 566-569; advance online publication, August 9, 2013; 10.1038/clpt.2013.158 Abstract | Full Text Integration of Pharmacometabolomic and Pharmacogenomic Approaches Reveals Novel Insights Into Antiplatelet Therapy J P Lewis, L M Yerges-Armstrong, S Ellero-Simatos, A Georgiades, R Kaddurah-Daouk and T Hankemeier Clin Pharmacol Ther 2013 94: 570-573; advance online publication, July 26, 2013; 10.1038/clpt.2013.153 Full Text State of the Art Top Cometabolism of Microbes and Host: Implications for Drug Metabolism and Drug-Induced Toxicity H Li and W Jia Clin Pharmacol Ther 2013 94: 574-581; advance online publication, August 9, 2013; 10.1038/clpt.2013.157 Abstract | Full Text Review Top Demonstrating Evidence of Acceptability: The “Catch-22” of Pediatric Formulation Development S Ranmal and C Tuleu Clin Pharmacol Ther 2013 94: 582-584; advance online publication, July 26, 2013; 10.1038/clpt.2013.154 Abstract | Full Text Research Top ARTICLES Conjunctive Therapy of Cisplatin With the OCT2 Inhibitor Cimetidine: Influence on Antitumor Efficacy and Systemic Clearance J A Sprowl, L van Doorn, S Hu, L van Gerven, P de Bruijn, L Li, A A Gibson, R H Mathijssen and A Sparreboom Clin Pharmacol Ther 2013 94: 585-592; advance online publication, July 17, 2013; 10.1038/clpt.2013.145 Abstract | Full Text Randomized, Double-Blind, Placebo-Controlled, Dose-Escalating Phase I, Healthy Subjects Study of Intravenous OPN-305, a Humanized Anti-TLR2 Antibody OPEN M Reilly, R M Miller, M H Thomson, V Patris, P Ryle, L McLoughlin, P Mutch, P Gilboy, C Miller, M Broekema, B Keogh, W McCormack and J  van de Wetering de Rooij Clin Pharmacol Ther 2013 94: 593-600; advance online publication, July 23, 2013; 10.1038/clpt.2013.150 Abstract | Full Text Evaluation of Endogenous Metabolic Markers of Hepatic CYP3A Activity Using Metabolic Profiling and Midazolam Clearance K-H Shin, M H Choi, K S Lim, K-S Yu, I-J Jang and J-Y Cho Clin Pharmacol Ther 2013 94: 601-609; advance online publication, June 19, 2013; 10.1038/clpt.2013.128 Abstract | Full Text Please note that you need to be a subscriber or site-license holder to enjoy full-text access to Clinical Pharmacology & Therapeutics. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Nature Publishing Group | 75 Varick Street, 9th Floor | New York | NY 10013-1917 | USA Nature Publishing Group's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS. © 2013 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.